Apellis Pharmaceuticals Overview

Life ScienceCompany

Was Apellis Pharmaceuticals formerly PE-backed?

Yes. Apellis Pharmaceuticals was formerly owned by 2 private investors.

Where is Apellis Pharmaceuticals headquartered?

Apellis Pharmaceuticals is headquartered in Waltham, Massachusetts.

What is Apellis Pharmaceuticals’ revenue?

Apellis Pharmaceuticals disclosed revenue of 781M USD for 2024 and 397M USD for 2023.

How many employees does Apellis Pharmaceuticals have?

Apellis Pharmaceuticals has 705 employees.

What sector is Apellis Pharmaceuticals in?

Apellis Pharmaceuticals is a life science company.

When was Apellis Pharmaceuticals founded?

Apellis Pharmaceuticals was founded in 2009.

Apellis Pharmaceuticals

Apellis Pharmaceuticals, Inc.

100 Fifth Avenue,
Waltham, Massachusetts 02451
United States,
(617) 977-5700
www.apellis.com

Apellis Pharmaceuticals is a clinical-stage biopharmaceutical company, focused on the development of a platform of novel therapeutic compounds for the treatment of a broad range of autoimmune diseases based upon complement immunotherapy. Uncontrolled complement activation can lead to a wide range of life-threatening or debilitating disorders. Apellis is the first company to advance chronic therapy with a C3 inhibitor into clinical trials. Apellis Pharmaceuticals was founded in 2009 and is headquartered in Waltham, Massachusetts.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.